Research in Rahway
Science Explorer records 2 research institutions in Rahway, United States. The highest-ranked on research quality in 2022–2025 are Merck & Co., Inc., Rahway, NJ, USA (United States).
- Research institutions
- 2 1 of them ranked worldwide
- Research works
- 18k ▲ 11% vs 2013–17
- Top-10% rate, 2022–2025
- 19.3% record average 16.5%
A city carries no overall standing here. The composite score is built for institutions and countries, the units its floors and field normalisation were designed around. An empty rank on this page is a statement about the measure, not about the place.
Which research institutions are in Rahway?
| # | Institution | Works | Against the largest here | World rank |
|---|---|---|---|---|
| 1 | Merck & Co., Inc., Rahway, NJ, USA (United States)Company | 17,631 | #1,130 | |
| 2 | Merck Institute for Science EducationNonprofit | 147 | #24,550 all time |
By fractional works over the whole record; world rank on research quality in 2022–2025. Bars are scaled to the largest institution in this city, not to anything off the page.
What is Rahway strongest at in research?
Relative to its size, research in Rahway is most concentrated in Pharmaceutical Science, Spectroscopy and Statistics and Probability (12.0× the world share in Pharmaceutical Science).
- Pharmaceutical ScienceSubfield · 22.7 works12×
- SpectroscopySubfield · 43.4 works11×
- Statistics and ProbabilitySubfield · 35.7 works9.5×
- Organic ChemistrySubfield · 90.1 works6.8×
- OncologySubfield · 131.4 works6.6×
Location quotient against the world baseline. Inside a single field a city is a meaningful unit, which is why this is where a city is measured at all.
Which keywords describe research in Rahway?
By fractional works in 2022–2025, weighted toward what it does more of than the world: Epidemiology, Monoclonal Antibodies, Chemotherapy, Therapeutic Antibodies, Tumor Microenvironment, Glycosylation, Immunogenicity and Biopharmaceuticals.
- Cancer Incidence
- Health Utility Measures
- Fc Receptors
- Antibody Engineering
- Pneumococcal Conjugate Vaccine
- Respiratory Infections
- Human Papillomavirus
- Vaccine Development
- Stability
- Protein Aggregation
- Immune Checkpoint Blockade
- Targeted Therapy
- Pathogenesis
- Medicinal Chemistry
- Biopharmaceuticals
- Biomarkers
- Immunotherapy
- Clinical Practice Guidelines
- Therapeutic Antibodies
- Monoclonal Antibodies
- Epidemiology
- Chemotherapy
- Tumor Microenvironment
- Clinical Trials
- Glycosylation
- Immunogenicity
- Vaccine
- Antimicrobial Resistance
- Immune Response
- Recombinant Proteins
- PD-1 and PD-L1
- Chromatography
- Drug Discovery
- Treatment Guidelines
- Vaccination
- Community-Acquired Pneumonia
- Monoclonal Antibody
- Economic Evaluation
- Cost-effectiveness Analysis
- Molecular Characterization
Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this city's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 40 words, with their numbers
- Epidemiology216▲ 3.1×90 topics
- Monoclonal Antibodies83▲ 52×3 topics
- Chemotherapy80▲ 6.4×21 topics
- Therapeutic Antibodies70▲ 57×2 topics
- Tumor Microenvironment61▲ 7.8×8 topics
- Clinical Practice Guidelines60▲ 6.3×13 topics
- Clinical Trials59▲ 5.0×14 topics
- Immunotherapy57▲ 4.6×18 topics
- Glycosylation56▲ 28×3 topics
- Biomarkers55▲ 4.6×18 topics
- Immunogenicity55▲ 73×3 topics
- Biopharmaceuticals55▲ 61×3 topics
- Vaccine54▲ 7.5×10 topics
- Medicinal Chemistry49▲ 10.0×12 topics
- Antimicrobial Resistance48▲ 14×9 topics
- Pathogenesis46▲ 5.1×19 topics
- Immune Response45▲ 4.5×18 topics
- Targeted Therapy45▲ 11×5 topics
- Recombinant Proteins42▲ 75×2 topics
- Immune Checkpoint Blockade41▲ 21×1 topic
- PD-1 and PD-L141▲ 21×1 topic
- Protein Aggregation40▲ 44×2 topics
- Chromatography40▲ 152×1 topic
- Stability40▲ 9.9×1 topic
- Drug Discovery39▲ 9.9×8 topics
- Vaccine Development38▲ 8.5×8 topics
- Treatment Guidelines34▲ 9.0×5 topics
- Human Papillomavirus32▲ 15×3 topics
- Vaccination30▲ 23×2 topics
- Respiratory Infections30▲ 15×3 topics
- Community-Acquired Pneumonia30▲ 50×1 topic
- Pneumococcal Conjugate Vaccine30▲ 50×1 topic
- Monoclonal Antibody30▲ 32×2 topics
- Antibody Engineering29▲ 30×1 topic
- Economic Evaluation29▲ 14×2 topics
- Fc Receptors29▲ 30×1 topic
- Cost-effectiveness Analysis29▲ 19×1 topic
- Health Utility Measures29▲ 19×1 topic
- Molecular Characterization29▲ 9.2×6 topics
- Cancer Incidence29▲ 12×4 topics
What research is done in Rahway?
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Cancer Immunotherapy and Biomarkers Oncology 41 works
- 2 Protein purification and stability Molecular Biology 40 works
- 3 Pneumonia and Respiratory Infections Epidemiology 30 works
- 4 Monoclonal and Polyclonal Antibodies Research Radiology, Nuclear Medicine and Imaging 29 works
- 5 Health Systems, Economic Evaluations, Quality of Life Economics and Econometrics 29 works
- 6 Respiratory viral infections research Epidemiology 26 works
- 7 Viral Infectious Diseases and Gene Expression in Insects Molecular Biology 22 works
- 8 Vaccine Coverage and Hesitancy Health 22 works
- 9 Analytical Chemistry and Chromatography Spectroscopy 22 works
- 10 Lung Cancer Treatments and Mutations Pulmonary and Respiratory Medicine 22 works
Research output over time
The same series as a ribbon — one cell per year, darker for more.